Close Menu

NEW YORK – On Wednesday, Cellex became the first firm to receive Emergency Use Authorization from the US Food and Drug Administration for a coronavirus serology test. The assay, which resembles a pregnancy test, is authorized for use in laboratories certified under CLIA to perform as moderate- and highly-complexity tests.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.